Evidence map›Paper›PMID 23339648›Full record

ReviewCritical reviews in biomedical engineering2012

Bone tissue engineering: recent advances and challenges.

Ami R Amini, Cato T Laurencin, Syam P Nukavarapu

Abstract readReview
In one paragraph

Review in Critical reviews in biomedical engineering, 2012. The graph could read no effect estimate from its abstract, so it casts no vote on the map. Cited by 820 papers, 2 of them syntheses that pooled it.

0numbers the graph read from it
0cells of the map it votes in
820citing papers in PubMed, 2 pooled it
35.8field-weighted citation impact, top 1% of its field
1 · What the graph read from it

What it found

Each row is one number read from the abstract, on the scale the paper reported it, with its interval. Left of the dashed line favours the treatment, right favours the comparator. Under each row is the sentence it came from. New to these charts? A ten-minute tutorial.

The abstract states no effect estimate the extractor could read, or names no intervention and outcome on the map, so this paper lights no cell and moves no belief. It is still indexed, cited and linked below.

2 · The registry

The trial behind it

Trials whose registry record cites this paper, or whose number appears in the abstract. A trial that started after this paper was published is citing it as background, not reporting it.

Neither the registry nor the abstract names a trial number. If this is a trial report, that itself is worth knowing.

3 · Its place in the literature

Who cites it

820 citing papers in PubMed, 2 syntheses or guidelines pooled it, 2,269 citations in OpenAlex.

  1. Pooled it
  2. Stem Cell-Based Tissue Engineering for Cleft Defects: Systematic Review and Meta-Analysis.The Cleft palate-craniofacial journal : official publication of the American Cleft Palate-Craniofacial Association · 2024
    Pooled it
  3. Article
  4. iScience · 2026
    Article
  5. Review
  6. Review
  7. Review
  8. Article
  9. Article
  10. Review
  11. Review
  12. Review
  13. Article
  14. Article
  15. Article
  16. Article
  17. Article
  18. Alveolar Bone Regeneration: Smart Biomaterials and Physical Stimulation.Journal of biomedical materials research. Part B, Applied biomaterials · 2026
    Review
  19. Article
  20. Article

760 more citing papers are in PubMed but not listed here.

4 · The record

Corrections and comments

PubMed lists nothing against this paper. Absence here is not a guarantee, only a check that was made.

5 · Who and what money

Authors and funding

3 authors at 1 institution in 1 country.

Ami R AminiDepartment of Orthopedic Surgery, University of Connecticut Health Center, Farmington, CT, USA.
Cato T Laurencin
Syam P Nukavarapu
UConn Health · US

Funding

Optimal Biodegradable Scaffolds and Progenitor Cells for Effective Bone RegeneratF30DE022477 · NIDCR · UNIVERSITY OF CONNECTICUT SCH OF MED/DNT · PI AMINI, AMI R · 2011 to 2013
$121k
NIDCR NIH HHS 1F30-DE22477010NIDCR NIH HHS F30 DE022477
6 · The paper itself

Abstract

The worldwide incidence of bone disorders and conditions has trended steeply upward and is expected to double by 2020, especially in populations where aging is coupled with increased obesity and poor physical activity. Engineered bone tissue has been viewed as a potential alternative to the conventional use of bone grafts, due to their limitless supply and no disease transmission. However, bone tissue engineering practices have not proceeded to clinical practice due to several limitations or challenges. Bone tissue engineering aims to induce new functional bone regeneration via the synergistic combination of biomaterials, cells, and factor therapy. In this review, we discuss the fundamentals of bone tissue engineering, highlighting the current state of this field. Further, we review the recent advances of biomaterial and cell-based research, as well as approaches used to enhance bone regeneration. Specifically, we discuss widely investigated biomaterial scaffolds, micro- and nano-structural properties of these scaffolds, and the incorporation of biomimetic properties and/or growth factors. In addition, we examine various cellular approaches, including the use of mesenchymal stem cells (MSCs), embryonic stem cells (ESCs), adult stem cells, induced pluripotent stem cells (iPSCs), and platelet-rich plasma (PRP), and their clinical application strengths and limitations. We conclude by overviewing the challenges that face the bone tissue engineering field, such as the lack of sufficient vascularization at the defect site, and the research aimed at functional bone tissue engineering. These challenges will drive future research in the field.

Indexed as

AnimalsBone DiseasesBone SubstitutesFractures, BoneHumansStem Cell TransplantationTissue EngineeringTissue ScaffoldsBone Substitutes

Identifiers

PMID23339648
PMCPMC3766369
OpenAlexW2007310752

What OpenQuestion holds

Textmetadata
LicenceTDM
Read underepoch 390

Registered trials

None linked

Read under generation 80e0d062 · epoch 390. Bibliography from PubMed, PubMed Central and OpenAlex; grants from NIH RePORTER; trial links from ClinicalTrials.gov; estimates, votes and beliefs from the OpenQuestion graph.